109 related articles for article (PubMed ID: 23727519)
1. Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women.
Hirth JM; Tan A; Wilkinson GS; Berenson AB
Am J Obstet Gynecol; 2013 Sep; 209(3):200.e1-7. PubMed ID: 23727519
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
3. Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females.
Hirth JM; Lin YL; Kuo YF; Berenson AB
Prev Med; 2016 Jul; 88():134-9. PubMed ID: 27085993
[TBL] [Abstract][Full Text] [Related]
4. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
Malo TL; Perkins RB; Lee JH; Vadaparampil ST
Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
[TBL] [Abstract][Full Text] [Related]
5. Changes over time in papanicolaou cytology test and HPV test in a large women's academic center laboratory.
Jones TE; Matsko J; Elishaev E; Clark BZ; Carter G; Harinath L; Zhao C
J Am Soc Cytopathol; 2023; 12(4):307-313. PubMed ID: 37142542
[TBL] [Abstract][Full Text] [Related]
6. Gynecologists and human papillomavirus DNA testing: exploring knowledge, attitudes, and practice in Italy.
Caglioti C; Pileggi C; Nobile CG; Pavia M
Eur J Cancer Prev; 2017 May; 26(3):249-256. PubMed ID: 27879494
[TBL] [Abstract][Full Text] [Related]
7. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Jin XW; Xu H
Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
[TBL] [Abstract][Full Text] [Related]
9. Detection of human papillomavirus in cervical biopsies of summer camp ROTC cadets with abnormal papanicolaou smears.
Stafford EM; Stewart RS; Teague GR; Gomez RR; Crothers BA; Michel TJ; Patience TH; Moore DC
J Pediatr Adolesc Gynecol; 1996 Aug; 9(3):119-24. PubMed ID: 8795786
[TBL] [Abstract][Full Text] [Related]
10. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
Hallett LD; Gerber MR
J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
[TBL] [Abstract][Full Text] [Related]
12. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
15. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening among young adult women in the United States.
Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
[TBL] [Abstract][Full Text] [Related]
17. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
18. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
[TBL] [Abstract][Full Text] [Related]
19. An assessment of gynecological cytology screening practices among health care providers nationwide.
Darwish-Yassine M; Garvin AD; Johnston CM; Zoschnick L; Conners A; Laing S; Wojcik C
Arch Pathol Lab Med; 2015 May; 139(5):650-5. PubMed ID: 25927148
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]